<DOC>
	<DOCNO>NCT02310425</DOCNO>
	<brief_summary>Immature gastrointestinal function increase risk poor growth well nosocomial infection necrotizing enterocolitis ( NEC ) preterm infant . The effect probiotic growth development premature infant investigate poorly . Saccharomyces boulardii CNCM I-745 ( S. boulardii ) non-pathogenic probiotic yeast . Prophylactic supplementation S. boulardii dose 50 mg/kg twice day appear bring preterm infant weight gain closer intra-uterine growth rate , reduce feed intolerance , adverse effect .</brief_summary>
	<brief_title>A Single Blinded Study Effect Saccharomyces Boulardii CNCM I-745 Growth Development Preterm Infants</brief_title>
	<detailed_description>The objective study evaluate feeding supplement S. boulardii improve growth clinical outcome preterm low birth weight infant . A prospective , randomized case-controlled trial conduct infant gestational age 30 37 week birth weight 1500 2500 g. The study group receive S. boulardii supplementation , 50 mg/kg twice daily , compare intervention control group . The primary outcome short term growth parameter include weight gain , linear growth , head chest circumference , secondary outcomes clinical outcome , feed intolerance complication . A total 125 infant enrol study , 63 treatment 62 control group . S. boulardii administer first time 2.63 day birth ( 1 day 6 day , 46 within 3 day , 5 4 6 day ) .</detailed_description>
	<mesh_term>Infant , Premature , Diseases</mesh_term>
	<criteria>The inclusion criterion hospital born infant gestational age 30 37 week birth weight 1500 2500 g. Exclusion criterion severe neonatal pathology birth complication , GI malformation , chromosomal abnormality , know immunodeficiency , hydrops foetalis , central venous catheter use antifungal drug probiotic .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>